CALHIV receiving multi-month ART including 6 months dispensation had better VL suppression rates. Retention rates however didn't differ by multi-month dispensing categories as observed among adults in the interval trial. We recommend multi-month ART dispensation including more than 6 months among CALHIV irrespective of their age, clinical stage, and history of prior co-morbidities.
No takes yet. Share an insight, caveat, or question.
Ainembabazi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: